Selective alpha-1 antagonists such as doxazosin are currently more widely used than phenoxybenzamine in the preoperative management of pheochromocytoma, primarily due to their availability, cost-effectiveness, and convenient once-daily dosing. This evidence concerns the gene PSMA6 and hereditary pheochromocytoma-paraganglioma.